Despite the unfavorable cerebrovascular changes observed in non-demented E2 allele carriers, E2/3 AD cases did not exhibit an augmented cerebrovascular phenotype in AD compared to the other APOE variants; their unique AD-related phenotype was typified by alterations in nucleic acid synthesis, transcriptional gene pathways and protein translation. The gene discussed is APOE; the disease is Alzheimer disease.